This data verified the efficiency of WES combined with postoperative data to identify candidate monogenic obesity genes and also identified c.1614dup (CAMKK2) as a promising MOV in a cohort of patients experiencing early-onset obesity. The gene discussed is CAMKK2; the disease is obesity disorder.